Dai Ichi Life Insurance Company Ltd grew its position in Clorox Company (The) (NYSE:CLX) by 7.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 79,018 shares of the company’s stock after purchasing an additional 5,507 shares during the period. Dai Ichi Life Insurance Company Ltd owned approximately 0.06% of Clorox Company (The) worth $10,528,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. American Beacon Advisors Inc. bought a new stake in Clorox Company (The) in the first quarter valued at approximately $104,000. Parkside Financial Bank & Trust grew its position in shares of Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after purchasing an additional 29 shares during the last quarter. Valley National Advisers Inc. grew its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after purchasing an additional 5 shares during the last quarter. Blue Chip Partners Inc. grew its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after purchasing an additional 6 shares during the last quarter. Finally, Zions Bancorporation grew its position in Clorox Company (The) by 5.6% during the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock worth $134,000 after buying an additional 53 shares in the last quarter. Institutional investors and hedge funds own 71.28% of the company’s stock.
A number of brokerages recently issued reports on CLX. BMO Capital Markets restated an “outperform” rating on shares of Clorox Company (The) in a research note on Tuesday, September 12th. Jefferies Group LLC reaffirmed a “hold” rating and set a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Barclays PLC reaffirmed an “equal weight” rating and set a $136.00 target price (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BidaskClub downgraded Clorox Company (The) from a “hold” rating to a “sell” rating in a report on Wednesday, July 5th. Finally, Zacks Investment Research upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target for the company in a report on Tuesday, July 4th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $127.81.
In related news, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Jon M. Balousek sold 9,223 shares of the stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. Insiders sold 21,242 shares of company stock valued at $2,944,449 over the last quarter. Company insiders own 0.74% of the company’s stock.
Clorox Company (NYSE:CLX) traded up 1.07% during trading on Friday, reaching $136.18. The company’s stock had a trading volume of 906,023 shares. The company has a 50-day moving average of $135.92 and a 200 day moving average of $135.24. Clorox Company has a one year low of $111.24 and a one year high of $141.76. The firm has a market cap of $17.58 billion, a PE ratio of 25.53 and a beta of 0.40.
Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.30 earnings per share. Analysts expect that Clorox Company will post $5.66 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 13th. Stockholders of record on Wednesday, October 25th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.47%. The ex-dividend date of this dividend is Tuesday, October 24th. Clorox Company (The)’s dividend payout ratio (DPR) is 63.04%.
Clorox Company (The) Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.